CTLA4 and cancer: Enhancers include interleukins, interferons, anti-cytotoxic T-lymphocyte-associated protein 4 (anti-CTLA4) antibodies, as well as the very currently presented genetically engineered T cells (e.g., CAR-T cells) and cancer-specific vaccines.